Home LATEST NEWS Hydroxychloroquine would help treat primary progressive multiple sclerosis

Hydroxychloroquine would help treat primary progressive multiple sclerosis

54
0

The Cummings School of Medicine research team, led by Dr Marcus Koch and Dr Wee Yong, found that the generic drug was able to slow the progression of this form of the disease which affects 15% of 90,000 Canadian patients diagnosed with multiple sclerosis.

My powers are limited, I can’t develop a new drug to cure PPMS. So we said to ourselves that we can study the generic drugs already on the market used for other diseases, says Dr. Marcus Koch.

By following several selection criteria, the other research director, Dr. Wee Yong, identified nearly 250 generic drugs likely to have a beneficial effect in the treatment of certain neurological diseases.

After an analysis of several data, some were chosen, including hydroxychloroquine, because they can enter the brain without poisoning it. We chose it because it has a lot of impact on microglial cells, explains Dr. Marcus Koch. The main purpose of these immune cells is to defend the central nervous system.

The research team intends to continue these studies to add another drug to hydroxychloroquine. Nevertheless, Dr. Koch would like the success of this study to inspire other researchers.

He explains that this new research model, called futility, makes it possible to study generic drugs to find out if they can be used in the treatment of other diseases.other research teams looking at generic drugs, so we can study them quickly”,”text”:”So I would like to see 20 more research teams looking at generic drugs, so we can study them quickly “}}”>I would therefore like to see 20 other research teams take an interest in generic drugs, so that we can study them quickly., concludes the researcher.

Previous articleIn Tonga, residents flee tsunami after volcano erupts
Next articleChina, Iran start implementing strategic deal